Company News, 2003-08-06, 02:00 AM
Uhde acquires shareholding in Chemgineering Group
With effect from October 1, 2003, Uhde GmbH, Dortmund, will acquire a shareholding in Chemgineering Holding AG, Muttenz (near Basel), Switzerland. At the same time the Chemgineering Group will take over the business of Heidelberg, Germany-based Uhde-Pharma Consult who specialise in the planning of pharmaceutical solid dosage facilities. This investment will create the basis for international strategic cooperation between the two complementary partners in major projects.
The strategic alliance between the two technological companies offers the life science branch the possibility to execute its projects from a single source through one strong engineering partner: from evaluation of the technology, project development and investment planning to the engineering and construction of the complete plant including the qualification and validation.
The Chemgineering Group currently employs some 160 employees at eight locations in Switzerland, Austria and Germany. In 2002 its turnover reached 33 million Swiss francs. The group provides technology consultancy and engineering services in the fields of pharmaceuticals, biotechnology and bulk chemicals as well as in related branches. As an SAP partner Chemgineering also advises its customers in the introduction and validation of special information systems and software solutions with high official requirements.
Uhde is a company in the Technologies segment of the ThyssenKrupp Group and has a workforce of 3,500 employees worldwide. The company`s activities focus on the design and construction of chemical and other industrial plants in the following fields: fertilisers, organic chemicals and plastics, electrolysis, oil, gas & refining technology and pharmaceuticals.
Andreas Beckers - Public Relations
Tel.+49 2 31 5 47 -2514
Fax +49 2 31 5 47 26 28